Company of Biologists
|Company of Biologists ‘Read and Publish’ pilot agreement
|Has the agreement been disclosed and published?
|01/01/2020 – 12/31/2022
|Consortia / Institution
Approximate range of annual corresponding author publications
|Less than 5
|Comments on size/article output
|Low article output with CoB, less than 5 articles per year
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Unlimited gratis OA publishing included as part of the subscription price
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|No risk sharing, uncapped, unlimited OA publishing. Price is unchanged, even in the event that no articles are published during the term.
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?
|CC-BY preference, exceptions allowed
|Original research articles
What is the approximate share of access related costs of the overall agreement?
|More than 50%
|Comments on access costs
|100% for Read, 0% for Publishing
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS
|Too early to assess
|OVERALL ASSESSMENT AND COMMENTS
|The agreement allows unlimited access to and open access publishing of research articles in the Company of Biologist hybrid titles. The price is based on current spend and fixed for the duration of the 3 year pilot, regardless of output.
|Request contact to the licensee
|contact [at] esac-initiative [dot] org